[1]
Reyes Abad, M., Alerany, C., Gonzalez, L.I., Neth, O., Payares-Herrera, C., Rodríguez-Gallego, C., Trillo, J.L., Herrmann, K.H., Figueiredo, R. and Gil, A. 2025. Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA). Global and Regional Health Technology Assessment. 12, 1 (Jan. 2025), 9–15. DOI:https://doi.org/10.33393/grhta.2025.3199.